Acetylsalicylic acid Recruiting Phase 3 Trials for Critical Limb Ischemia (CLI) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04229264Efficacy and Safety of Apixaban in Reducing Restenosis and Limb Loss in PAD Patients.